© The Author 2006. Published by Oxford University Press.
ARTICLE |
Reliability of Self-Reported Family History of Cancer in a Large Case–Control Study of Lymphoma
Affiliations of authors: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (ETC, KES, H-OA); Northern California Cancer Center, Fremont, CA (ETC); Department of Epidemiology Research, Danish Epidemiology Science Center, Statens Serum Institut, Copenhagen, Denmark (HH); Department of Oncology, Radiology and Clinical Immunology, University of Uppsala, Uppsala, Sweden; and Department of Oncology and Pathology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden (BG)
Correspondence to: Ellen Chang, ScD, Northern California Cancer Center, 2201 Walnut Ave., Suite 300, Fremont, CA 94538 (e-mail: ellen{at}nccc.org).
Background: Case–control studies of familial cancer risk traditionally rely on self-reported family history of cancer, which may bias results due to differential recall between case patients and control subjects. To evaluate the reliability of self-reported data, we analyzed questionnaire and registry-based data on familial cancer from a population-based case–control study of malignant lymphoma. Methods: All 1508 lymphoma case patients and 1229 control subjects completed a telephone interview assessing cancer in family members. Participants were linked to the Swedish Multi-Generation Register and Cancer Register to identify confirmed cancer diagnoses in first-degree relatives. The sensitivity and specificity of self-reported familial cancer were calculated among case patients and control subjects and were compared using logistic regression. All statistical tests were two-sided. Results: Lymphoma case patients reported a family history of any cancer with statistically significantly higher sensitivity than control subjects (0.85, 95% confidence interval [CI] = 0.83 to 0.87 and 0.80, 95% CI = 0.77 to 0.82, respectively) but with marginally lower specificity (0.89, 95% CI = 0.87 to 0.91 and 0.92, 95% CI = 0.90 to 0.94, respectively). The sensitivity of self-reporting familial cancers by site ranged from less than 0.20 for rare malignancies to nearly 0.75 for more common types, whereas specificity was generally 0.98 or greater. For most sites, the reliability of self-report was similar in patients and control subjects. However, patients reported familial hematopoietic cancer with statistically significantly higher sensitivity (0.60, 95% CI = 0.57 to 0.62) than control subjects (0.38, 95% CI = 0.35 to 0.40). Odds ratios for the association between familial cancer and risk of non-Hodgkin lymphoma were consistently higher when based on self-reported, compared with registry data-based, family history of any cancer or of hematopoietic cancer. Conclusions: Reliability of self-reported family history of cancer varies between case patients and control subjects. Recall bias may thus produce biased results in case–control studies of familial cancer risk.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Hemminki, J. Sundquist, and J. Lorenzo Bermejo Familial Risks for Cancer as the Basis for Evidence-Based Clinical Referral and Counseling Oncologist, March 1, 2008; 13(3): 239 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hemminki, J. Sundquist, and J. L. Bermejo How common is familial cancer? Ann. Onc., January 1, 2008; 19(1): 163 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Touze and P. M. Rothwell Sex Differences in Heritability of Ischemic Stroke: A Systematic Review and Meta-Analysis Stroke, January 1, 2008; 39(1): 16 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Smedby, H. Hjalgrim, E. T. Chang, K. Rostgaard, B. Glimelius, H.-O. Adami, and M. Melbye Childhood Social Environment and Risk of Non Hodgkin Lymphoma in Adults Cancer Res., November 15, 2007; 67(22): 11074 - 11082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Czene, H.-O. Adami, and E. T. Chang Sex- and Kindred-Specific Familial Risk of Non Hodgkin's Lymphoma Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2496 - 2499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Wang, S. L. Slager, P. Brennan, E. A. Holly, S. De Sanjose, L. Bernstein, P. Boffetta, J. R. Cerhan, M. Maynadie, J. J. Spinelli, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph) Blood, April 15, 2007; 109(8): 3479 - 3488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mensah, E. Willett, P Ansell, P. Adamson, and E Roman Non-Hodgkin's Lymphoma and Family History of Hematologic Malignancy Am. J. Epidemiol., January 15, 2007; 165(2): 126 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Risch, J. R. McLaughlin, D. E. C. Cole, B. Rosen, L. Bradley, I. Fan, J. Tang, S. Li, S. Zhang, P. A. Shaw, et al. Population BRCA1 and BRCA2 Mutation Frequencies and Cancer Penetrances: A Kin-Cohort Study in Ontario, Canada J Natl Cancer Inst, December 6, 2006; 98(23): 1694 - 1706. [Abstract] [Full Text] [PDF]
|
|